A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer. - Hamm C; Fifield BA; Kay A; Kulkarni S; Gupta R; Mathews J; Ferraiuolo RM; Al-Wahsh H; Mailloux E; Hussein A; Porter LA (Medical oncology (Northwood, London, England), 2022)